{"id":"fluticasone-azelastine-nasal-spray","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Dysgeusia (bitter taste)"},{"rate":null,"effect":"Somnolence"}]},"_chembl":{"chemblId":"CHEMBL1676","moleculeType":"Small molecule","molecularWeight":"538.58"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluticasone propionate is a potent intranasal corticosteroid that suppresses inflammatory mediators and immune cell activation in nasal tissue. Azelastine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses. Together, they provide dual anti-inflammatory and antihistamine effects for allergic rhinitis management.","oneSentence":"Fluticasone/Azelastine combines a corticosteroid that reduces inflammation with an antihistamine that blocks allergic responses in the nasal passages.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:40.326Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"}]},"trialDetails":[{"nctId":"NCT07415278","phase":"PHASE4","title":"INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pamukkale University","startDate":"2022-12-01","conditions":"Allergic Rhinitis","enrollment":61},{"nctId":"NCT02402465","phase":"PHASE4","title":"Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02","conditions":"Allergic Rhinitis","enrollment":22},{"nctId":"NCT05080322","phase":"PHASE4","title":"Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis","status":"RECRUITING","sponsor":"Zheng Liu ENT","startDate":"2021-09-09","conditions":"Allergic Rhinitis","enrollment":150},{"nctId":"NCT06180083","phase":"PHASE1","title":"Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2023-03-24","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":56},{"nctId":"NCT05158972","phase":"","title":"Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2021-10-27","conditions":"Allergic Rhinitis","enrollment":924},{"nctId":"NCT04601324","phase":"PHASE4","title":"Allergic Rhinitis Combination Pharmacotherapy Efficacy Study","status":"WITHDRAWN","sponsor":"St. Paul's Sinus Centre","startDate":"2020-12-15","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT06051786","phase":"PHASE2","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Synmosa Biopharma Corp.","startDate":"2020-08-20","conditions":"Allergic Rhinitis","enrollment":136},{"nctId":"NCT04652245","phase":"PHASE4","title":"Dymista Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2020-12-14","conditions":"Seasonal Allergic Rhinitis","enrollment":216},{"nctId":"NCT03599791","phase":"PHASE3","title":"DYmista NAsal Spray in CHInese Patients","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2018-06-29","conditions":"Allergic Rhinitis","enrollment":900},{"nctId":"NCT03004131","phase":"PHASE4","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2017-01-07","conditions":"Seasonal Allergic Rhinitis","enrollment":82},{"nctId":"NCT01190852","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01194622","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT02230696","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":951},{"nctId":"NCT02953106","phase":"PHASE4","title":"Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2017-01-20","conditions":"Asthma, Allergic, Rhinitis,Allergic, Allergy","enrollment":7},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT02238353","phase":"PHASE4","title":"AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)","status":"UNKNOWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-10","conditions":"Allergic Rhinitis, House Dust Mite Allergy","enrollment":45},{"nctId":"NCT01915823","phase":"PHASE3","title":"Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-07","conditions":"Seasonal Allergic Rhinitis","enrollment":348},{"nctId":"NCT01794741","phase":"PHASE3","title":"3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2013-02","conditions":"Allergic Rhinitis","enrollment":405},{"nctId":"NCT02279563","phase":"PHASE2","title":"A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Apotex Inc.","startDate":"2013-12","conditions":"Seasonal Allergic Rhinitis","enrollment":595},{"nctId":"NCT02249663","phase":"PHASE3","title":"Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™","status":"UNKNOWN","sponsor":"Teva Pharmaceuticals USA","startDate":"2014-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1535},{"nctId":"NCT00883168","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2009-04","conditions":"Seasonal Allergic Rhinitis","enrollment":1791},{"nctId":"NCT00651118","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2008-03","conditions":"Seasonal Allergic Rhinitis","enrollment":832},{"nctId":"NCT00740792","phase":"PHASE3","title":"A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2008-08","conditions":"Seasonal Allergic Rhinitis","enrollment":776},{"nctId":"NCT00660517","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2007-12","conditions":"Seasonal Allergic Rhinitis","enrollment":607},{"nctId":"NCT00845598","phase":"PHASE4","title":"Azelastine Fluticasone Combination vs. Fluticasone","status":"WITHDRAWN","sponsor":"University of Dundee","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT00845195","phase":"PHASE4","title":"Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-03","conditions":"Seasonal Allergic Rhinitis","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dymista"],"phase":"marketed","status":"active","brandName":"Fluticasone/Azelastine nasal spray","genericName":"Fluticasone/Azelastine nasal spray","companyName":"University of Chicago","companyId":"university-of-chicago","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluticasone/Azelastine combines a corticosteroid that reduces inflammation with an antihistamine that blocks allergic responses in the nasal passages. Used for Allergic rhinitis (seasonal and perennial).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}